FDA Updates
Published: 01/23/2025
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
The following is a listing of recent U.S. Food and Drug Administration updates and activities.
- FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication
- Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis